Sarcopenia is a geriatric condition featured by a progressive loss of muscle mass and
function and associated with various adverse health outcomes. In this review, we aimed to …

The gut microbiota represents a 'metabolic organ'that can regulate human metabolism. Intact
gut microbiota contributes to host homeostasis, whereas compositional perturbations …

Sarcopenia is a progressive skeletal muscle disease that occurs most commonly in the
elderly population, contributing to increased costs and hospitalization. Exercise and …

With aging, the progressive loss of skeletal muscle will have negative effect on multiple
physiological parameters, such as exercise, respiration, thermoregulation, and metabolic …

Recent research has revealed causes other than aging that may induce sarcopenia in
young people, contrary to the long-studied age-dependent reduction in muscular mass and …

Increasing evidence suggests that metabolites produced by the gut microbiota play a crucial
role in host–microbe interactions. Dietary tryptophan ingested by the host enters the gut …

Low muscle mass combined with changes in physical function and muscle quality is defined
as sarcopenia. In people> 60 years, sarcopenia reaches 10% and tends to increase with …

Probiotics have shown potential to counteract sarcopenia, although the extent to which they
can influence domains of sarcopenia such as muscle mass and strength in humans is …

Aging is associated with a decline in skeletal muscle mass and function—termed sarcopenia—
as mediated, in part, by muscle anabolic resistance. This metabolic phenomenon describes …

Sarcopenia is a common skeletal muscle disorder, characterised by a loss of muscle mass
and impaired muscle function, that is associated with poorer health outcomes. While …